Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xuping Xie and Pei-Yong Shi.
Xuping Xie
Connection Strength
9.932
Pei-Yong Shi
  1. Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2021 Jun 21; 12(1):3984.
    View in: PubMed
    Score: 0.952
  2. Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera. Nat Med. 2021 04; 27(4):620-621.
    View in: PubMed
    Score: 0.928
  3. Engineering SARS-CoV-2 using a reverse genetic system. Nat Protoc. 2021 03; 16(3):1761-1784.
    View in: PubMed
    Score: 0.927
  4. A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19. Nat Commun. 2020 10 15; 11(1):5214.
    View in: PubMed
    Score: 0.908
  5. An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020 05 13; 27(5):841-848.e3.
    View in: PubMed
    Score: 0.877
  6. Small Molecules and Antibodies for Zika Therapy. J Infect Dis. 2017 12 16; 216(suppl_10):S945-S950.
    View in: PubMed
    Score: 0.746
  7. Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 Jul; 595(7865):E1.
    View in: PubMed
    Score: 0.238
  8. Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2021 Jun 22; 12(1):4000.
    View in: PubMed
    Score: 0.238
  9. BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants. Nature. 2021 08; 596(7871):273-275.
    View in: PubMed
    Score: 0.238
  10. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants. N Engl J Med. 2021 07 29; 385(5):472-474.
    View in: PubMed
    Score: 0.236
  11. The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization. NPJ Vaccines. 2021 Mar 25; 6(1):44.
    View in: PubMed
    Score: 0.234
  12. Neutralizing Activity of BNT162b2-Elicited Serum. N Engl J Med. 2021 04 15; 384(15):1466-1468.
    View in: PubMed
    Score: 0.233
  13. A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
    View in: PubMed
    Score: 0.233
  14. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
    View in: PubMed
    Score: 0.227
  15. Evasion of Type I Interferon by SARS-CoV-2. Cell Rep. 2020 10 06; 33(1):108234.
    View in: PubMed
    Score: 0.226
  16. A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation. Nat Commun. 2020 08 13; 11(1):4059.
    View in: PubMed
    Score: 0.224
  17. Using a Virion Assembly-Defective Dengue Virus as a Vaccine Approach. J Virol. 2018 11 01; 92(21).
    View in: PubMed
    Score: 0.198
  18. Potential Mechanisms for Enhanced Zika Epidemic and Disease. ACS Infect Dis. 2018 05 11; 4(5):656-659.
    View in: PubMed
    Score: 0.188
  19. Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep. 2017 Oct 31; 21(5):1180-1190.
    View in: PubMed
    Score: 0.185
  20. A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage. Nat Commun. 2017 09 22; 8(1):676.
    View in: PubMed
    Score: 0.184
  21. A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients. EBioMedicine. 2017 Mar; 17:157-162.
    View in: PubMed
    Score: 0.177
  22. A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine. EBioMedicine. 2017 Mar; 17:145-156.
    View in: PubMed
    Score: 0.176
  23. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis. EBioMedicine. 2017 Feb; 16:136-140.
    View in: PubMed
    Score: 0.175
  24. Reverse Genetics of Zika Virus. Methods Mol Biol. 2017; 1602:47-58.
    View in: PubMed
    Score: 0.175
  25. Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells. Antimicrob Agents Chemother. 2021 08 17; 65(9):e0060221.
    View in: PubMed
    Score: 0.060
  26. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 Jul 01; 12(1):4177.
    View in: PubMed
    Score: 0.060
  27. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021 08; 596(7870):109-113.
    View in: PubMed
    Score: 0.060
  28. Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease. Cell Host Microbe. 2021 07 14; 29(7):1151-1161.e5.
    View in: PubMed
    Score: 0.060
  29. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature. 2021 08; 596(7870):103-108.
    View in: PubMed
    Score: 0.060
  30. Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature. 2021 07; 595(7869):718-723.
    View in: PubMed
    Score: 0.059
  31. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med. 2021 04; 27(4):717-726.
    View in: PubMed
    Score: 0.058
  32. SARS-CoV-2 Infects Human Engineered Heart Tissues and Models COVID-19 Myocarditis. JACC Basic Transl Sci. 2021 Apr; 6(4):331-345.
    View in: PubMed
    Score: 0.058
  33. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation. Sci Rep. 2021 01 26; 11(1):2229.
    View in: PubMed
    Score: 0.058
  34. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
    View in: PubMed
    Score: 0.058
  35. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
    View in: PubMed
    Score: 0.058
  36. Inhibition of Coronavirus Entry In Vitro and Ex Vivo by a Lipid-Conjugated Peptide Derived from the SARS-CoV-2 Spike Glycoprotein HRC Domain. mBio. 2020 10 20; 11(5).
    View in: PubMed
    Score: 0.057
  37. Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses. Antiviral Res. 2020 10; 182:104874.
    View in: PubMed
    Score: 0.056
  38. Fragile X mental retardation protein is a Zika virus restriction factor that is antagonized by subgenomic flaviviral RNA. Elife. 2018 12 04; 7.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.